Bioscience Firm Serologicals Set for Major Expansion at Its Dundee Site

Summary

---

AMERICAN bioscience firm Serologicals is embarking on a major expansion of its UK operations. Its Dundee and Southampton businesses will be the main beneficiaries.

David Dodd, chief executive of Serologicals, has revealed that the drug discovery business segment of its Chemicon and Upstate subsidiary companies is now headquartered in Dundee and that the facility would be responsible for a wider portfolio of products to be used by researchers in the development of new medicines.

See the full content of this document

Extract

---

Bioscience Firm Serologicals Set for Major Expansion at Its Dundee Site

Dodd estimated that sales at its drug discovery business, including the Dundee site, would gro...

See the full content of this document

---